» Articles » PMID: 34579085

The Effect of Dietary Interventions on Chronic Inflammatory Diseases in Relation to the Microbiome: A Systematic Review

Overview
Journal Nutrients
Date 2021 Sep 28
PMID 34579085
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic inflammation plays a central role in the pathophysiology of various non-communicable diseases. Dietary interventions can reduce inflammation, in part due to their effect on the gut microbiome. This systematic review aims to determine the effect of dietary interventions, specifically fiber intake, on chronic inflammatory diseases and the microbiome. It aims to form hypotheses on the potential mediating effects of the microbiome on disease outcomes after dietary changes. Included were clinical trials which performed a dietary intervention with a whole diet change or fiber supplement (>5 g/day) and investigated the gut microbiome in patients diagnosed with chronic inflammatory diseases such as cardiovascular disease (CVD), type 2 diabetes (T2DM), and autoimmune diseases (e.g., rheumatoid arthritis (RA), inflammatory bowel disease (IBD)). The 30 articles which met the inclusion criteria had an overall moderate to high risk of bias and were too heterogeneous to perform a meta-analysis. Dietary interventions were stratified based on fiber intake: low fiber, high fiber, and supplemental fiber. Overall, but most pronounced in patients with T2DM, high-fiber plant-based dietary interventions were consistently more effective at reducing disease-specific outcomes and pathogenic bacteria, as well as increasing microbiome alpha diversity and short-chain fatty acid (SCFA)-producing bacteria, compared to other diets and fiber supplements.

Citing Articles

Specific Composition Diets and Improvement of Symptoms of Immune-Mediated Inflammatory Diseases in Adulthood-Could the Comparison Between Diets Be Improved?.

Guerrero Aznar M, Villanueva Guerrero M, Beltran Garcia M, Hernandez Cruz B Nutrients. 2025; 17(3).

PMID: 39940351 PMC: 11819864. DOI: 10.3390/nu17030493.


From Evidence to Practice: A Narrative Framework for Integrating the Mediterranean Diet into Inflammatory Bowel Disease Management.

Naik R, Purcell S, Gold S, Christiansen V, DAloisio L, Raman M Nutrients. 2025; 17(3).

PMID: 39940329 PMC: 11821149. DOI: 10.3390/nu17030470.


Anti-Inflammatory and Prebiotic Potential of Ethanol Extracts and Mucilage Polysaccharides from Korean Yams ( and ).

Park S, Truong V, Jeon S, Choe S, Rarison R, Yoon B Foods. 2025; 14(2).

PMID: 39856842 PMC: 11764955. DOI: 10.3390/foods14020173.


Understanding Predictors of Crohn's Disease: Determinants of Altered Barrier Function in Pre-Disease Phase of Crohn's Disease.

Neustaeter A, Leibovitzh H, Turpin W, Croitoru K J Can Assoc Gastroenterol. 2025; 7(1):68-77.

PMID: 39834755 PMC: 10836969. DOI: 10.1093/jcag/gwad052.


Dietary Patterns and Fibre Intake Are Associated with Disease Activity in Australian Adults with Inflammatory Bowel Disease: An Exploratory Dietary Pattern Analysis.

Cosier D, Lambert K, Charlton K, Batterham M, Little R, Wu N Nutrients. 2025; 16(24).

PMID: 39770970 PMC: 11677955. DOI: 10.3390/nu16244349.


References
1.
Kjeldsen-Kragh J, Haugen M, Borchgrevink C, Laerum E, Eek M, Mowinkel P . Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet. 1991; 338(8772):899-902. DOI: 10.1016/0140-6736(91)91770-u. View

2.
Candela M, Biagi E, Soverini M, Consolandi C, Quercia S, Severgnini M . Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet. Br J Nutr. 2016; 116(1):80-93. PMC: 4894062. DOI: 10.1017/S0007114516001045. View

3.
Nestle M . Mediterranean diets: historical and research overview. Am J Clin Nutr. 1995; 61(6 Suppl):1313S-1320S. DOI: 10.1093/ajcn/61.6.1313S. View

4.
Blander J, Longman R, Iliev I, Sonnenberg G, Artis D . Regulation of inflammation by microbiota interactions with the host. Nat Immunol. 2017; 18(8):851-860. PMC: 5800875. DOI: 10.1038/ni.3780. View

5.
Horvath A, Leber B, Feldbacher N, Tripolt N, Rainer F, Blesl A . Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study. Eur J Nutr. 2019; 59(7):2969-2983. PMC: 7501130. DOI: 10.1007/s00394-019-02135-w. View